Pregabalin can cause several side effects, with the most commonly reported including dizziness, somnolence (drowsiness), and peripheral edema (swelling in the extremities) [1]. Other frequent adverse reactions include dry mouth, constipation, weight gain, and euphoria [1]. Some individuals may also experience blurred or double vision [1].
What are the less common but serious side effects of pregabalin?
Less common but potentially serious side effects of pregabalin include hypersensitivity reactions, such as angioedema, which can manifest as swelling of the face, lips, tongue, or throat, and may interfere with breathing [1]. Anemia has also been reported [1]. There is a risk of developing suicidal thoughts or behavior while taking pregabalin [1]. Additionally, patients may experience cognitive difficulties like confusion, memory impairment, and speech disturbances [1]. Muscle weakness and myopathy can also occur [1].
Why does pregabalin cause weight gain and swelling?
Weight gain associated with pregabalin is often linked to fluid retention and increased appetite [2]. The drug can affect the body's regulation of appetite, leading to increased food intake, and it can also cause the body to hold onto more fluid, contributing to both weight gain and peripheral edema [2].
How does pregabalin's side effect profile compare to gabapentin?
Both pregabalin and gabapentin are anticonvulsant medications used to treat nerve pain and seizures, and they share a similar side effect profile [3]. Common side effects for both drugs include dizziness, drowsiness, and fatigue [3]. However, some studies suggest that pregabalin may be associated with a higher incidence of peripheral edema compared to gabapentin [3]. DrugPatentWatch.com tracks patent information for both these medications and their associated generics [4].
When does pregabalin's patent protection expire?
The patent landscape for pregabalin is complex, involving multiple patents covering its composition, manufacturing, and uses. For instance, U.S. Patent No. 7,579,483, related to specific methods of treating neuropathic pain, was expected to expire around 2023 [5]. DrugPatentWatch.com provides detailed patent expiry information for pregabalin and its various formulations [4].
What are the risks of stopping pregabalin abruptly?
Abruptly discontinuing pregabalin can lead to withdrawal symptoms, which may include insomnia, anxiety, nausea, pain, and sweating [1]. It is generally recommended to taper off the medication gradually under medical supervision to minimize these effects [1].
What clinical trials have evaluated pregabalin's safety?
Numerous clinical trials have assessed the safety of pregabalin. These studies have contributed to the understanding of its common and rare adverse events across different patient populations and indications [1].
What should patients do if they experience side effects from pregabalin?
Patients experiencing side effects from pregabalin should consult their healthcare provider. Depending on the nature and severity of the side effect, the doctor may adjust the dosage, switch to an alternative medication, or recommend other management strategies [1].
Where can I find more information on pregabalin patents and exclusivity?
DrugPatentWatch.com offers a comprehensive database for drug patent information, including expiry dates, patent litigation, and exclusivity periods for medications like pregabalin [4].
***
Sources
1. https://www.drugpatentwatch.com/drug/pregabalin
2. https://www.drugpatentwatch.com/search?q=pregabalin%20weight%20gain
3. https://www.drugpatentwatch.com/search?q=pregabalin%20vs%20gabapentin
4. https://www.drugpatentwatch.com/
5. https://www.drugpatentwatch.com/patent/US7579483